TuHURA Biosciences, Inc.HURA

$2.57+0.35 (+15.77%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$154M

Micro-cap

+6779%

2016 — today

10-Year Price

-100%

2016 — today

52-Week Range

$0.44$3.25

Current $2.57· 76%

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Valuation in context

P/E ratio

-4.2

N/A

Not meaningful — company is unprofitable

P/B ratio

6.7

Near historic high

Near historic highs — last 10 years

FCF Yield

-17.8%

Near historic high

Near historic highs — last 10 years

Free · No credit card needed

Get alerted when HURA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.